PTSD Trial, Recruiting NCT05560113 Sponsor: Emory University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05560113
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and sign a consent form agreeing to take part in the study
  • You are willing to participate in the study
  • You have no history of muscle, bone, or joint problems, or any neurological (brain or nerve) conditions
  • For participants in the PTSD group: you have been formally diagnosed with PTSD by a healthcare professional

Who may not be able to join:

  • You fall outside the age range required for this study (confirm with trial site for the specific age range)
  • You show signs of dementia, as measured by a standard memory and thinking test
  • You have a history of a serious head injury, a brain-degenerating condition, or have had substance abuse issues within the last 6 months
  • You have recently taken medications that affect brain activity or learning (confirm with trial site for specific medications)
  • You have any medical reasons why you cannot safely have TMS (a type of brain stimulation) or MRI scans, if those parts of the study apply to you
  • You are currently taking any medications that affect your mood, thoughts, or mental health
  • You are currently experiencing symptoms of psychosis or bipolar disorder, as assessed by study staff
  • You are under 18 years old, pregnant, or currently a prisoner
  • You are an adult who is unable to provide your own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Borich, PhD, Emory University

Phone: 404-712-5512

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 November 2022
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in Neural Connections: Functional network connectivity; Changes in Neural Connections: Regional activation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov